|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2007-9-5
|
|
pubmed:abstractText |
Chronic liver disease is characterized by inflammation and fibrosis. As a consequence angiogenesis leading to new vasculature may have prognostic value in disease progression. Interfering with angiogenesis may be a potential target to avoid progression of liver disease. Hence we planned to evaluate the CD34 and vascular endothelial growth factor (VEGF), the markers for angiogenesis in chronic liver disease.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1665-2681
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
6
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
170-3
|
|
pubmed:meshHeading |
pubmed-meshheading:17786144-Adult,
pubmed-meshheading:17786144-Aged,
pubmed-meshheading:17786144-Aged, 80 and over,
pubmed-meshheading:17786144-Antigens, CD34,
pubmed-meshheading:17786144-Biological Markers,
pubmed-meshheading:17786144-Biopsy,
pubmed-meshheading:17786144-Chronic Disease,
pubmed-meshheading:17786144-Disease Progression,
pubmed-meshheading:17786144-Female,
pubmed-meshheading:17786144-Humans,
pubmed-meshheading:17786144-Liver,
pubmed-meshheading:17786144-Liver Diseases,
pubmed-meshheading:17786144-Male,
pubmed-meshheading:17786144-Middle Aged,
pubmed-meshheading:17786144-Neovascularization, Pathologic,
pubmed-meshheading:17786144-Vascular Endothelial Growth Factor A
|
|
pubmed:articleTitle |
Angiogenesis in chronic liver disease.
|
|
pubmed:affiliation |
Department of Pathology, BYL Nair Charitable Hospital and TN Medical College, India.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
